Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck names manufacturing and R&D sites slated for closure

July 12, 2010
Manufacturing and Production, Research and Development Merck, job cuts, manufacturing, research and development

Merck & Co has taken an axe to its network of manufacturing and R&D sites around the world, closing down …

News

Digital Pharma: NICE launches mobile evidence service

July 9, 2010
Medical Communications Digital Pharma blog, NHS Evidence, NICE, evidence-based medicine

NICE has launched a mobile version of its online clinical evidence portal NHS Evidence. The beta version of the service …

News

Pfizer plant ready to milk Asian infant formula market

July 9, 2010
Manufacturing and Production Pfizer, Singapore, manufacturing, nutrition

Pfizer has spent $100 million to double the size of a manufacturing facility in Singapore to help it boost its …

News

Astellas Pharma censured over advisory boards

July 9, 2010
Medical Communications, Sales and Marketing Astellas, Code of Practice, PMCPA

Astellas has been the subject of ‘naming and shaming’ advertisements in three medical journals after advisory board meetings it ran …

News
European flags

European call for greater HTA co-operation

July 9, 2010
Sales and Marketing hta

The European Commissioner who oversees the pharma sector has called for greater co-operation on health technology assessment. John Dalli, the …

News

Daisy Thomas joins Hill & Knowlton

July 9, 2010
Medical Communications Hill & Knowlton, appointment, medical communications

Hill & Knowlton has appointed Daisy Thomas as an account director to its Healthcare & Wellbeing team. She joins from …

Appointment

Germany raises health premiums to tackle budget deficit

July 9, 2010
Sales and Marketing Germany, economic climate, insurance

Chancellor Angela Merkel’s coalition government has agreed to raise health insurance premiums by over half a percent in a further …

News

Novel anticoagulants set to lead atrial fibrillation market

July 9, 2010
Sales and Marketing Brinavess, Multaq, Pradaxa, Xarelto, apixaban, atrial fibrilation

Novel anticoagulants set to capture the atrial fibrillation market by 2019, according to a new report. Analysts Decision Resources say …

News
UK Biobank

Milestone for UK Biobank

July 8, 2010
Research and Development DNA, MRC, UK Biobank, Wellcome

Medical research initiative the UK Biobank has collected DNA samples from its 500,000th volunteer, marking a major milestone in its …

News

Government has mandate for NHS reform, says Dorrell

July 8, 2010
NHS, government

In return for ringfencing the NHS’s budget, the government now has a strong mandate for reforming health services, says the …

News

Pharming forges production deal with Sanofi Chimie

July 8, 2010
Manufacturing and Production, Sales and Marketing HAE, Pharming, Ruconest, Sanofi Chimie

Dutch biotechnology group Pharming has signed a toll manufacturing agreement with Sanofi Chimie in order to boost commercial-scale manufacturing of …

News

Dr Eliseo Salinas joins Elan

July 8, 2010
Research and Development Elan, appointment, research and development

Elan has appointed Dr Eliseo Oreste Salinas as executive VP and chief medical officer with responsibility for leading the company’s …

Appointment

NICE poised to reject Novartis’ Afinitor

July 8, 2010
Sales and Marketing Afinitor, NICE, Novartis

Novartis’ kidney cancer drug Afinitor does not offer enough benefit to patients to justify its cost, according to draft guidance …

News
GSK alli iPhone app

Digital Pharma: Big pharma’s iPhone apps (part three)

July 7, 2010
Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, ipad, iphone

In the first two parts of Big Pharma’s iPhone Apps I looked at apps produced by 11 of the largest …

Feature

Roche submits new version of Herceptin for US approval

July 7, 2010
Research and Development, Sales and Marketing Herceptin, Roche, breast cancer

Roche has submitted a new version of its blockbuster Herceptin (trastuzumab) to US regulators for approval to treat advanced breast …

News
GenzymeGate

EMA panel advises Fabrazyme switch

July 7, 2010
Manufacturing and Production Fabrazyme, Genzyme, manufacturing compliance

Doctors in Europe have been told they should consider switching patients with Fabry disease away from treatment with Genzyme’s Fabrazyme …

News

Italy plans cancer drug price cut

July 7, 2010
Sales and Marketing Italy, economic climate, global pricing, price cuts, pricing

Italy will cut drug prices next year as it adopts a ‘pay for performance’ approach to drug pricing. This will …

News
Biogen_Scangos

George Scangos to head up Biogen

July 7, 2010
Research and Development Biogen, appointment, research and development

Biogen Idec has appointed George Scangos chief executive officer, with effect from 15 July. Scangos will join the company from …

Appointment

4Sight launches conference division

July 7, 2010
Medical Communications, Sales and Marketing 4Sight, Performance Meetings, sales and marketing

UK pharma commercial services company 4Sight has launched a conference division. The Bracknell, UK-based firm’s Performance Meetings division will be …

News

European scrutiny of pharma patent deals to continue

July 6, 2010
Sales and Marketing European Commission, competition, patents

Europe’s drug watchdog has served notice that it will keep up scrutiny of pharma patent settlements to ensure they are …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026